Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsShares Issued
Ratios

Amylyx Pharmaceuticals (AMLX) Shares Issued (2021 - 2025)

Historic Shares Issued for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $2.7 million.

  • Amylyx Pharmaceuticals' Shares Issued rose 44154.79% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 6512.23%. This contributed to the annual value of $2.1 million for FY2024, which is 6951.67% down from last year.
  • Amylyx Pharmaceuticals' Shares Issued amounted to $2.7 million in Q3 2025, which was up 44154.79% from $72000.0 recorded in Q2 2025.
  • In the past 5 years, Amylyx Pharmaceuticals' Shares Issued registered a high of $200.9 million during Q1 2022, and its lowest value of $3000.0 during Q2 2021.
  • In the last 5 years, Amylyx Pharmaceuticals' Shares Issued had a median value of $419000.0 in 2023 and averaged $13.4 million.
  • As far as peak fluctuations go, Amylyx Pharmaceuticals' Shares Issued skyrocketed by 64795483.87% in 2022, and later tumbled by 9823.84% in 2023.
  • Over the past 5 years, Amylyx Pharmaceuticals' Shares Issued (Quarter) stood at $145000.0 in 2021, then surged by 138449.66% to $200.9 million in 2022, then plummeted by 99.83% to $347000.0 in 2023, then plummeted by 57.35% to $148000.0 in 2024, then surged by 1696.62% to $2.7 million in 2025.
  • Its Shares Issued stands at $2.7 million for Q3 2025, versus $72000.0 for Q2 2025 and $970000.0 for Q1 2025.